258 related articles for article (PubMed ID: 12433825)
1. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
[TBL] [Abstract][Full Text] [Related]
2. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
Obach RS
Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
[TBL] [Abstract][Full Text] [Related]
3. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
Obach RS
Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific binding of drugs to human liver microsomes.
McLure JA; Miners JO; Birkett DJ
Br J Clin Pharmacol; 2000 May; 49(5):453-61. PubMed ID: 10792203
[TBL] [Abstract][Full Text] [Related]
5. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
Poulin P; Haddad S
J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
[TBL] [Abstract][Full Text] [Related]
6. Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.
Mohutsky MA; Chien JY; Ring BJ; Wrighton SA
Pharm Res; 2006 Apr; 23(4):654-62. PubMed ID: 16550474
[TBL] [Abstract][Full Text] [Related]
7. Non-specific binding of compounds in
Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S
Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269
[TBL] [Abstract][Full Text] [Related]
8. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
Soars MG; Burchell B; Riley RJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
[TBL] [Abstract][Full Text] [Related]
9. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
10. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets.
Winiwarter S; Chang G; Desai P; Menzel K; Faller B; Arimoto R; Keefer C; Broccatell F
Mol Pharm; 2019 Sep; 16(9):4077-4085. PubMed ID: 31348668
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic Clearance Assay Incubational Binding: A Method Comparison.
Chen S; Prieto Garcia L; Bergström F; Nordell P; Grime K
Drug Metab Dispos; 2017 Apr; 45(4):342-345. PubMed ID: 28122786
[TBL] [Abstract][Full Text] [Related]
13. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.
Giuliano C; Jairaj M; Zafiu CM; Laufer R
Drug Metab Dispos; 2005 Sep; 33(9):1319-24. PubMed ID: 15951446
[TBL] [Abstract][Full Text] [Related]
14. The prediction of human clearance from hepatic microsomal metabolism data.
Obach RS
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
[TBL] [Abstract][Full Text] [Related]
15. A Fragment-Based Approach for the Computational Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes.
Nair PC; McKinnon RA; Miners JO
Drug Metab Dispos; 2016 Nov; 44(11):1794-1798. PubMed ID: 27543205
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.
Bowman CM; Benet LZ
Pharm Res; 2019 May; 36(8):113. PubMed ID: 31152241
[TBL] [Abstract][Full Text] [Related]
17. Structure-based prediction of the nonspecific binding of drugs to hepatic microsomes.
Li H; Sun J; Sui X; Yan Z; Sun Y; Liu X; Wang Y; He Z
AAPS J; 2009 Jun; 11(2):364-70. PubMed ID: 19440845
[TBL] [Abstract][Full Text] [Related]
18. Lack of appreciable species differences in nonspecific microsomal binding.
Zhang Y; Yao L; Lin J; Gao H; Wilson TC; Giragossian C
J Pharm Sci; 2010 Aug; 99(8):3620-7. PubMed ID: 20229604
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of empirical and physiological approaches on predicting human clearances.
Tamaki S; Komura H; Kogayu M; Yamada S
J Pharm Sci; 2011 Mar; 100(3):1147-55. PubMed ID: 20830811
[TBL] [Abstract][Full Text] [Related]
20. Application of the fluorescent probe 1-anilinonaphthalene-8-sulfonate to the measurement of the nonspecific binding of drugs to human liver microsomes.
McLure JA; Birkett DJ; Elliot DJ; Williams JA; Rowland A; Miners JO
Drug Metab Dispos; 2011 Sep; 39(9):1711-7. PubMed ID: 21610127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
